Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
Yang JF, Hsieh MY, Hou NJ, Dai CY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chuang WL, Yu ML. Yang JF, et al. Among authors: hou nj. Aliment Pharmacol Ther. 2009 May 1;29(9):1000-10. doi: 10.1111/j.1365-2036.2009.03957.x. Epub 2009 Feb 7. Aliment Pharmacol Ther. 2009. PMID: 19210290 Free article.
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
Hsu PY, Liang PC, Chang WT, Lu MY, Wang WH, Chuang SC, Wei YJ, Jang TY, Yeh ML, Huang CI, Lin YH, Wang CW, Hsieh MY, Hou NJ, Hsieh MH, Tsai YS, Ko YM, Lin CC, Chen KY, Dai CY, Lin ZY, Chen SC, Chuang WL, Huang CF, Huang JF, Yu ML. Hsu PY, et al. Among authors: hou nj. Am J Cancer Res. 2022 Dec 15;12(12):5576-5588. eCollection 2022. Am J Cancer Res. 2022. PMID: 36628276 Free PMC article.
Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.
Jang TY, Lin YH, Liang PC, Yeh ML, Huang CI, Liu TW, Wei YJ, Hsu PY, Yang JF, Hou NJ, Wang CW, Hsieh MY, Lin ZY, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Jang TY, et al. Among authors: hou nj. Kaohsiung J Med Sci. 2022 Sep;38(9):897-906. doi: 10.1002/kjm2.12563. Epub 2022 Jun 7. Kaohsiung J Med Sci. 2022. PMID: 35670210 Free article.
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Hsu PY, Cheng TS, Chuang SC, Chang WT, Liang PC, Hsu CT, Wei YJ, Jang TY, Yeh ML, Huang CI, Lin YH, Wang CW, Hsieh MY, Hou NJ, Hsieh MH, Tsai YS, Ko YM, Lin CC, Chen KY, Dai CY, Lin ZY, Chen SC, Huang JF, Chuang WL, Huang CF, Yu ML. Hsu PY, et al. Among authors: hou nj. Cancer Med. 2022 Jan;11(1):104-116. doi: 10.1002/cam4.4430. Epub 2021 Nov 16. Cancer Med. 2022. PMID: 34786871 Free PMC article.
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.
Jang TY, Huang CF, Yeh ML, Huang CI, Dai CY, Tsai PC, Hsu PY, Wei YJ, Hou NJ, Liang PC, Lin YH, Wang CW, Hsieh MY, Lin ZY, Huang JF, Yu ML, Chuang WL. Jang TY, et al. Among authors: hou nj. Kaohsiung J Med Sci. 2022 Mar;38(3):261-267. doi: 10.1002/kjm2.12474. Epub 2021 Nov 16. Kaohsiung J Med Sci. 2022. PMID: 34786828 Free article.
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.
Huang JF, Dai CY, Huang CF, Tsai PC, Yeh ML, Hsu PY, Huang SF, Bair MJ, Hou NJ, Huang CI, Liang PC, Lin YH, Wang CW, Hsieh MY, Chen SC, Lin ZY, Yu ML, Chuang WL. Huang JF, et al. Among authors: hou nj. Hepatol Int. 2021 Oct;15(5):1136-1147. doi: 10.1007/s12072-021-10242-2. Epub 2021 Aug 12. Hepatol Int. 2021. PMID: 34386935 Clinical Trial.
64 results